Stay updated with breaking news from Nasdaq Bdsi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioDelivery Sciences International, Inc. (NASDAQ:BDSI – Get Rating) has been given an average rating of “Hold” by the ten research firms that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and two have issued a buy recommendation on the […]
Brokerages expect BioDelivery Sciences International, Inc. (NASDAQ:BDSI – Get Rating) to announce earnings per share (EPS) of $0.08 for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for BioDelivery Sciences International’s earnings. BioDelivery Sciences International posted earnings per share of $0.05 in the same quarter last year, which would […]
BioDelivery Sciences International, Inc. (NASDAQ:BDSI – Get Rating) has been given an average rating of “Hold” by the ten brokerages that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and three have issued a buy recommendation on the company. […]
Wall Street analysts expect that BioDelivery Sciences International, Inc. (NASDAQ:BDSI – Get Rating) will post sales of $41.84 million for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for BioDelivery Sciences International’s earnings, with estimates ranging from $41.00 million to $42.60 million. BioDelivery Sciences International posted sales of $42.17 million in […]
BioDelivery Sciences International (NASDAQ:BDSI – Get Rating) announced its quarterly earnings data on Wednesday. The specialty pharmaceutical company reported $0.62 EPS for the quarter, beating the consensus estimate of $0.02 by $0.60, Fidelity Earnings reports. BioDelivery Sciences International had a net margin of 18.81% and a return on equity of 27.47%. Shares of BioDelivery Sciences […]